These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Dendritic cell vaccination and other strategies to tip the balance of the immune system : DC2007 5th International Meeting, July 16-18, Bamberg, Germany. Schaft N; Birkholz K; Hofmann C; Schmid M; Theiner G; Dörrie J Cancer Immunol Immunother; 2008 Jun; 57(6):913-28. PubMed ID: 18236041 [No Abstract] [Full Text] [Related]
10. The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy. Cannon MJ; Block MS; Morehead LC; Knutson KL Immunotherapy; 2019 Feb; 11(2):75-79. PubMed ID: 30730268 [No Abstract] [Full Text] [Related]
11. Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy. Seya T; Takeda Y; Takashima K; Yoshida S; Azuma M; Matsumoto M Proc Jpn Acad Ser B Phys Biol Sci; 2018; 94(3):153-160. PubMed ID: 29526974 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy exploiting the versatility of dendritic cells. Kadowaki N Ther Apher Dial; 2003 Jun; 7(3):312-7. PubMed ID: 12924606 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cell vaccine and cancer treatment: new patents. Aleixo AA; Michelin MA; Murta EF Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):26-9. PubMed ID: 24397783 [TBL] [Abstract][Full Text] [Related]
14. The hybrid cell vaccination approach to cancer immunotherapy. Trefzer U; Herberth G; Sterry W; Walden P Ernst Schering Res Found Workshop; 2000; (30):154-66. PubMed ID: 10943322 [No Abstract] [Full Text] [Related]
15. Monocyte-derived dendritic cells: a promising armament for immunotherapy in human malignancies. Yi Q; Kwak LW Clin Cancer Res; 2005 Feb; 11(3):966-7. PubMed ID: 15709160 [No Abstract] [Full Text] [Related]
16. Active immunization against cancer with dendritic cells: the near future. Steinman RM; Dhodapkar M Int J Cancer; 2001 Nov; 94(4):459-73. PubMed ID: 11745430 [No Abstract] [Full Text] [Related]
18. Modulation of Dendritic Cells by Nanotechnology-Based Immunotherapeutic Strategies. Mogrão J; da Costa CA; Gaspar R; Florindo HF J Biomed Nanotechnol; 2016 Mar; 12(3):405-34. PubMed ID: 27280242 [TBL] [Abstract][Full Text] [Related]
19. The therapeutic role of dendritic cells in cancer immunotherapy. Lemoli RM; Curti A; Fogli M; Ferri E; Baccarani M Haematologica; 2002 Aug; 87(8 Suppl):62-6. PubMed ID: 12412393 [No Abstract] [Full Text] [Related]
20. In situ vaccination with biocompatibility controllable immuno-sensitizer inducing antitumor immunity. Shin H; Na K Biomaterials; 2019 Mar; 197():32-40. PubMed ID: 30639548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]